A study showing that decreased risk of Type 2 Diabetes appears to be connected to a group of fatty acids called trans-palmitoleate has been published by researchers at Harvard University.

To examine connections between the presence of atherogenic dyslipidemia, circulating trans-palmitoleate and lower insulin resistance, and incident diabetes, more research was suggested by researchers.

Among 3736 American adults taking part in the Cardiovascular Health Study, CHS, relationship between plasma phospholipid trans-palmitoleate and metabolic risk factors and incident type 2 diabetes was looked at by researchers.

The authors said, “Our findings may explain previously observed metabolic benefits of dairy consumption and support the need for detailed further experimental and clinical investigation.”

A fatty acid derived mainly from dairy consumption is trans-palmitoleate acid.

The report’s authors noted that the effects of many individual fatty acids are not well understood, while fatty acids are powerful modulators of physiologic function.

Direct regulation and protection against insulin resistance and metabolic dysregulation may happen due to circulating palmitoleic acid, which arises out of endogenous fat synthesis, as animal experiments have shown that.

Due in large part to varying lifestyle factors as well as inconsistent tissue sampling, the results of human studies have been less conclusive.

It has also been noted that many factors could influence the effects of fatty acids on metabolic outcomes as they are complex.